Plasmodium falciparum Kelch-13 artemisinin partial resistance markers in Fort Portal, Western Uganda, 2024.

IF 4.1 2区 医学 Q2 MICROBIOLOGY
Antimicrobial Agents and Chemotherapy Pub Date : 2025-06-04 Epub Date: 2025-04-23 DOI:10.1128/aac.01755-24
Welmoed van Loon, Emma Schallenberg, Emmanuel Mande, Patrick Musinguzi, Paul Ngobi, Sharon Atukunda, John Rubaihayo, Frank P Mockenhaupt
{"title":"<i>Plasmodium falciparum Kelch-13</i> artemisinin partial resistance markers in Fort Portal, Western Uganda, 2024.","authors":"Welmoed van Loon, Emma Schallenberg, Emmanuel Mande, Patrick Musinguzi, Paul Ngobi, Sharon Atukunda, John Rubaihayo, Frank P Mockenhaupt","doi":"10.1128/aac.01755-24","DOIUrl":null,"url":null,"abstract":"<p><p>In Fort Portal, Uganda, artemisinin resistance-associated mutations in <i>Plasmodium falciparum Kelch13</i> (<i>n</i> = 126) were present in 4.8% (675V, 561H, and 441L). A mutation of unknown relevance, 490T, occurred in 9.5%. <i>PfMDR1</i> variants suggested increased lumefantrine tolerance (N86, 100%). Mutation 500N was absent, and 199S occurred in 12.8%. The latter is of unknown relevance. These data indicate an incipient emergence of artemisinin resistance in a crucial location between Rwandan and Ugandan resistance hotspots and hardly affected DR Congo.</p>","PeriodicalId":8152,"journal":{"name":"Antimicrobial Agents and Chemotherapy","volume":" ","pages":"e0175524"},"PeriodicalIF":4.1000,"publicationDate":"2025-06-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12135530/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Antimicrobial Agents and Chemotherapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1128/aac.01755-24","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/4/23 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

In Fort Portal, Uganda, artemisinin resistance-associated mutations in Plasmodium falciparum Kelch13 (n = 126) were present in 4.8% (675V, 561H, and 441L). A mutation of unknown relevance, 490T, occurred in 9.5%. PfMDR1 variants suggested increased lumefantrine tolerance (N86, 100%). Mutation 500N was absent, and 199S occurred in 12.8%. The latter is of unknown relevance. These data indicate an incipient emergence of artemisinin resistance in a crucial location between Rwandan and Ugandan resistance hotspots and hardly affected DR Congo.

2024年乌干达西部波特尔堡恶性疟原虫Kelch-13青蒿素部分耐药标记
在乌干达的Fort Portal,恶性疟原虫Kelch13 (n = 126)存在与青蒿素耐药相关的突变,占4.8% (675V、561H和441L)。9.5%发生了相关性未知的突变490T。PfMDR1变异表明增加了氟芳汀耐受性(N86, 100%)。突变500N缺失,突变199S占12.8%。后者是未知的相关性。这些数据表明,在卢旺达和乌干达耐药热点之间的关键地点以及几乎未受影响的刚果民主共和国,出现了青蒿素耐药性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
10.00
自引率
8.20%
发文量
762
审稿时长
3 months
期刊介绍: Antimicrobial Agents and Chemotherapy (AAC) features interdisciplinary studies that build our understanding of the underlying mechanisms and therapeutic applications of antimicrobial and antiparasitic agents and chemotherapy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信